PIOGLITAZONE VERSUS VITAMIN E VERSUS PLACEBO FOR THE TREATMENT OF NONDIABETIC

吡格列酮与维生素 E 与安慰剂治疗非糖尿病患者的比较

• 批准号: 7608216
• 负责人: Arthur McCullough
• 金额: $ 0.59万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608216
• 关键词: Alcohol consumption; Alcoholic Hepatitis; Clinical; Computer Retrieval of Information on Scientific Projects Database; Condition; Disease; Funding; Grant; Histology; Institution; Liver; Liver Cirrhosis; Microscope; Obesity; Outcome; Patient observation; Pioglitazone; Placebos; Research; Research Personnel; Resources; Source; Tissues; United States National Institutes of Health; Vitamins; Woman; diabetic; non-diabetic; nonalcoholic steatohepatitis

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The term "nonalcoholic steatohepatitis "(NASH)" was used to describe the initial observation of patients with conditions produced by a disease found in obese, diabetic women with no extreme alcohol intake. The liver tissue when looked under the microscope, (histology) was similar to alcoholic hepatitis. NASH is a common disease and can have serious clinical outcomes such as liver cirrhosis with its complications that are associated with this liver condition.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 术语“非酒精性脂肪性肝炎“（NASH）”用于描述患有由肥胖、糖尿病女性中发现的疾病引起的疾病的患者的初步观察，这些女性没有极端的酒精摄入。 肝组织在显微镜下观察时，（组织学）与酒精性肝炎相似。 NASH是一种常见的疾病，可能具有严重的临床结果，如肝硬化及其与这种肝脏疾病相关的并发症。